Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio Key International (BKYI) Free Cash Flow (2016 - 2025)

Bio Key International's Free Cash Flow history spans 16 years, with the latest figure at -$1.1 million for Q3 2025.

  • For Q3 2025, Free Cash Flow rose 13.34% year-over-year to -$1.1 million; the TTM value through Sep 2025 reached -$3.4 million, up 15.3%, while the annual FY2024 figure was -$2.9 million, 22.86% up from the prior year.
  • Free Cash Flow for Q3 2025 was -$1.1 million at Bio Key International, down from -$881490.0 in the prior quarter.
  • Across five years, Free Cash Flow topped out at $295215.0 in Q1 2024 and bottomed at -$3.2 million in Q1 2021.
  • The 5-year median for Free Cash Flow is -$1.4 million (2024), against an average of -$1.3 million.
  • The largest YoY upside for Free Cash Flow was 115.31% in 2024 against a maximum downside of 753.83% in 2024.
  • A 5-year view of Free Cash Flow shows it stood at -$1.9 million in 2021, then dropped by 4.12% to -$2.0 million in 2022, then rose by 21.47% to -$1.5 million in 2023, then soared by 67.08% to -$504564.0 in 2024, then crashed by 122.78% to -$1.1 million in 2025.
  • Per Business Quant, the three most recent readings for BKYI's Free Cash Flow are -$1.1 million (Q3 2025), -$881490.0 (Q2 2025), and -$839882.0 (Q1 2025).